Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease Read more
Liminal Custody Secures Key ADGM FSP License, Reinforcing Leadership in Digital Asset Custody Read more
